Colon Cancer: Molecular Oncology Tumor Boards

This free case-based activity includes a crowd-sourced discussion of a 51-year-old female patient that had a colonoscopy that revealed a large non-obstructing mass in the ascending colon. A biopsy confirmed invasive adenocarcinoma and elevated CEA at 35ng/ML. No evidence of active bleeding and labs confirmed normal liver, kidney, and marrow function. Her pathologic and genomic profiling results are discussed, along with the significance of the findings for her family in relation to hereditary colorectal cancer.

Originally posted on a forum in the ASCO Connection, participants now have the opportunity to claim CME, MOC, completion, or participation certificates for completing this activity.

Learning Objectives

  • Recognize molecular tests necessary for optimal management of colorectal cancer
  • Intergrate genetic and genomic testing for hereditary colorectal cancer into clinical practice
  • Identify the role of immunotherapy as an emerging treatment for MSI-H colorectal cancer

Continuing Education Credit

1 Credit/Point is available for participation in this course. Certificate and credit types available include:

  • AMA PRA Category 1 Credits™ 
  • ABIM MOC Points
  • CNE Contact Hours
  • CPE Credits
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.
Important Notes
  • This course expires on May 24, 2020. Participants must complete all necessary course components by this date to receive credit.